
Retatrutide 10mg Research Vial
Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling.
Tirzepatide 40mg is a lyophilised dual-receptor peptide in a sealed vial, for larger in vitro metabolic studies.

Tirzepatide 40mg is a lyophilised dual-receptor peptide in a sealed vial, for larger in vitro metabolic studies.
Price shown is for a single 40mg vial. The final amount is confirmed at checkout. Need a different amount? Send an inquiry.
Tirzepatide 40mg is a lyophilised dual-receptor peptide in a sealed vial, for larger in vitro metabolic studies. The 40mg vial is the largest Tirzepatide strength, intended for research programmes that require a substantial supply. The compound is studied in vitro for how activity at the GIP and GLP-1 receptors relates to metabolic signalling. It arrives freeze-dried in a sealed container, labelled with its 40mg nominal content. A batch-specific report documents the analysis of the lot, and CAS 2023788-19-2 is recorded for reference. AthloPep restricts this material to laboratory research and makes no claim about effects in people. This listing is for the 40mg vial. The material is identified by CAS number 2023788-19-2.
| Labelled amount | 40mg |
|---|---|
| Form | Lyophilised powder |
| CAS number | 2023788-19-2 |
| Intended use | In vitro laboratory research |
Every vial is supplied with an analytical report prepared for its own batch. The report records identity and purity results for the submitted sample. Match the batch identifier on the report to the vial you receive before use.
Tirzepatide 40mg is a lyophilised dual-receptor peptide in a sealed vial, for larger in vitro metabolic studies. It is supplied as a lyophilised, sealed research vial and is not a medicine.
The vial is labelled with a nominal 40mg of material. The figure is the stated content of the vial, not a solution concentration, and should be checked against the batch documentation before use.
Yes. Each listing links to the analytical report prepared for the specific batch. The report records identity and purity results for the submitted sample and should be matched to the vial you receive.
It arrives as a freeze-dried powder in a sealed vial. Keep the container closed and follow the storage conditions printed on the label and any handling sheet supplied with the lot.
No. AthloPep supplies this material for in vitro laboratory research only. It is not for human or animal consumption and no therapeutic use is implied.
The listed unit price for this vial is $198. Prices are shown in US dollars and the final amount is confirmed on the checkout page before payment.

Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling.

Retatrutide 15mg is a lyophilised research peptide supplied as a single, sealed vial for metabolic receptor studies in vitro.

Retatrutide 20mg is a lyophilised research peptide in a sealed vial, intended for laboratory studies of metabolic and receptor pathways.

Retatrutide 30mg is a sealed, lyophilised research vial for in vitro work on metabolic receptor signalling.
Tell us what you need. An email address is required so we can reply.